9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
Inhibrx Biosciences, Inc
Nurix Therapeutics, Inc.
AbbVie
DEKA Biosciences
Eli Lilly and Company
GlaxoSmithKline
Stanford University
Fox Chase Cancer Center
City of Hope Medical Center
University of Michigan Rogel Cancer Center
GlaxoSmithKline
National Institutes of Health Clinical Center (CC)